Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Oral AOD9604 for obesity: a Phase IIb study
Final dosage, treatment recommendations, and program length are determined during consultation with a licensed healthcare provider
By avoiding the growth hormone receptor/IGF-1 pathway entirely, AOD-9604 eliminates the appetite-modulating effects that make growth hormone therapy challenging for weight management
Classified as a growth hormonederived metabolic signaling peptide, AOD 9604 functions as a selective modulator of adipose tissue pathways, enabling targeted investigation of lipolysis without engagement of canonical growth hormone receptor signaling
Why 157 Matters That number represents the specific amino acid sequence that gives this peptide its power
Just dont count on it to do the heavy lifting alone
